$7.73
0.293.83%
At close: -
$7.73
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
AdaptHealth Analyst Ratings and Price Targets | NASDAQ:AHCO | Benzinga
AdaptHealth Corp has a consensus price target of $13.88 based on the ratings of 10 analysts. The high is $30 issued by SVB Leerink on November 10, 2022. The low is $6.5 issued by B of A Securities on November 8, 2023. The 3 most-recent analyst ratings were released by Baird, Canaccord Genuity, and RBC Capital on February 27, 2025, February 26, 2025, and February 26, 2025, respectively. With an average price target of $14.67 between Baird, Canaccord Genuity, and RBC Capital, there's an implied 89.74% upside for AdaptHealth Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
Canaccord Genuity
RBC Capital
Truist Securities
UBS
1calculated from analyst ratings
Analyst Ratings for AdaptHealth
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | Buy Now | 106.99% | Baird | Eric Coldwell78% | $14 → $16 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | 81.11% | Canaccord Genuity | Richard Close43% | $13 → $14 | Maintains | Buy | Get Alert |
| 02/26/2025 | Buy Now | 81.11% | RBC Capital | Ben Hendrix58% | $11 → $14 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | 81.11% | Truist Securities | David Macdonald64% | $12 → $14 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 42.3% | UBS | Whit Mayo67% | $12 → $11 | Maintains | Buy | Get Alert |
| 11/19/2024 | Buy Now | 42.3% | RBC Capital | Ben Hendrix58% | $13 → $11 | Maintains | Outperform | Get Alert |
| 11/15/2024 | Buy Now | 55.24% | Truist Securities | David Macdonald64% | $13 → $12 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 55.24% | UBS | Whit Mayo67% | $13 → $12 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 68.18% | Canaccord Genuity | Richard Close43% | $14 → $13 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 81.11% | Baird | Eric Coldwell78% | $16 → $14 | Maintains | Outperform | Get Alert |
| 08/12/2024 | Buy Now | 68.18% | RBC Capital | Ben Hendrix58% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2024 | Buy Now | 68.18% | Truist Securities | David Macdonald64% | $13 → $13 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | 68.18% | RBC Capital | Ben Hendrix58% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | Buy Now | 68.18% | UBS | Whit Mayo67% | $9 → $13 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 68.18% | Truist Securities | David Macdonald64% | $11 → $13 | Maintains | Buy | Get Alert |
| 01/29/2024 | Buy Now | 16.43% | UBS | Whit Mayo67% | $10 → $9 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 68.18% | RBC Capital | Ben Hendrix58% | $18 → $13 | Maintains | Outperform | Get Alert |
| 11/08/2023 | Buy Now | -15.91% | B of A Securities | Kevin Fischbeck68% | → $6.5 | Downgrade | Neutral → Underperform | Get Alert |
| 11/08/2023 | Buy Now | 42.3% | Truist Securities | David Macdonald64% | $14 → $11 | Maintains | Buy | Get Alert |
| 10/11/2023 | Buy Now | 81.11% | Truist Securities | David Macdonald64% | $18 → $14 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | 42.3% | B of A Securities | Joanna Gajuk64% | $13 → $11 | Maintains | Neutral | Get Alert |
| 07/13/2023 | Buy Now | 171.67% | Baird | Eric Coldwell78% | $20 → $21 | Maintains | Outperform | Get Alert |
| 06/28/2023 | Buy Now | 158.73% | Baird | Eric Coldwell78% | → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 06/27/2023 | Buy Now | 158.73% | Baird | Eric Coldwell78% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 05/11/2023 | Buy Now | 132.86% | RBC Capital | Ben Hendrix58% | $24 → $18 | Maintains | Outperform | Get Alert |
| 05/10/2023 | Buy Now | 119.92% | Canaccord Genuity | Richard Close43% | $22 → $17 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 94.05% | Truist Securities | David Macdonald64% | $17 → $15 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 158.73% | Baird | Eric Coldwell78% | $23 → $20 | Maintains | Outperform | Get Alert |
| 05/10/2023 | Buy Now | 46.18% | Deutsche Bank | Pito Chickering67% | $28 → $11.3 | Downgrade | Buy → Hold | Get Alert |
| 05/10/2023 | Buy Now | 42.3% | Stifel | Mathew Blackman59% | $18 → $11 | Downgrade | Buy → Hold | Get Alert |
| 05/09/2023 | Buy Now | 55.24% | B of A Securities | Joanna Gajuk64% | $21 → $12 | Downgrade | Buy → Neutral | Get Alert |
| 04/13/2023 | Buy Now | 119.92% | Truist Securities | David Macdonald64% | $20 → $17 | Maintains | Buy | Get Alert |
| 03/01/2023 | Buy Now | 197.54% | Baird | Eric Coldwell78% | $31 → $23 | Maintains | Outperform | Get Alert |
| 11/10/2022 | Buy Now | 288.1% | SVB Leerink | Whit Mayo67% | $29 → $30 | Maintains | Outperform | Get Alert |
| 09/20/2022 | Buy Now | 262.23% | Deutsche Bank | Pito Chickering67% | $26 → $28 | Maintains | Buy | Get Alert |
| 09/19/2022 | Buy Now | 262.23% | Truist Securities | David Macdonald64% | $26 → $28 | Maintains | Buy | Get Alert |
| 08/10/2022 | Buy Now | 275.16% | RBC Capital | Ben Hendrix58% | $26 → $29 | Maintains | Outperform | Get Alert |
| 08/10/2022 | Buy Now | 275.16% | SVB Leerink | Whit Mayo67% | $24 → $29 | Maintains | Outperform | Get Alert |
| 07/14/2022 | Buy Now | 210.48% | Truist Securities | David Macdonald64% | $20 → $24 | Maintains | Buy | Get Alert |
FAQ
What is the target price for AdaptHealth (AHCO) stock?
The latest price target for AdaptHealth (NASDAQ:AHCO) was reported by Baird on February 27, 2025. The analyst firm set a price target for $16.00 expecting AHCO to rise to within 12 months (a possible 106.99% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AdaptHealth (AHCO)?
The latest analyst rating for AdaptHealth (NASDAQ:AHCO) was provided by Baird, and AdaptHealth maintained their outperform rating.
When was the last upgrade for AdaptHealth (AHCO)?
There is no last upgrade for AdaptHealth
When was the last downgrade for AdaptHealth (AHCO)?
The last downgrade for AdaptHealth Corp happened on November 8, 2023 when B of A Securities changed their price target from N/A to $6.5 for AdaptHealth Corp.
When is the next analyst rating going to be posted or updated for AdaptHealth (AHCO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AdaptHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AdaptHealth was filed on February 27, 2025 so you should expect the next rating to be made available sometime around February 27, 2026.
Is the Analyst Rating AdaptHealth (AHCO) correct?
While ratings are subjective and will change, the latest AdaptHealth (AHCO) rating was a maintained with a price target of $14.00 to $16.00. The current price AdaptHealth (AHCO) is trading at is $7.73, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
